One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Doximity cleared that benchmark Thursday, with a jump from 78 to 83 Thursday.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's proprietary rating measures share price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the best stocks tend to have an 80 or higher RS Rating as they begin their biggest runs.
Doximity is not currently showing a potential entry point. See if the stock goes on to form a base that could launch a new move.
Doximity posted 29% earnings growth last quarter. Revenue increased 15%.
Doximity holds the No. 3 rank among its peers in the Computer Software-Medical industry group. OptimizeRx is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
